Print
25 February 2015
The Economic Times
NEW DELHI: The government will shortly come out with strategies to improve bulk drug manufacturing capacity in India in order to reduce dependence on China for import of bulk drugs.
"We are importing 70-80 per cent bulk drugs from China. We will shortly come out with strategies to improve our bulk drug capacity in India.
There was a time when India was producing bulk drugs in a big way and now nothing," Pharmaceuticals Secretary V K Su .. There was a time when India was producing bulk drugs in a big way and now nothing," Pharmaceuticals Secretary V K Subburaj said at an event organised by industry body Assocham.
He said the committee set up by the government has submitted its recommendations and the Department of Pharmaceuticals is examining it and will come out with its strategies shortly.
These strategies will be part of the proposed bulk drug pharma policy.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.